⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

January 1, 2026Molecular Therapy

Highly efficient and durable Th1-biased protective immunity from a novel mRNA vaccine against RSV via AI-assisted antigen screening

Kai Dong Fang Liu Man Zhang Yuting Zhou Fei Yu Wang Wang Xin Chai Jing Li G. Song

View at Publisher

Ask AI

Bookmark

Share

Key Points

The mRNA vaccine generates significant Th1-biased immunity, which is crucial for protection against RSV.
Findings indicate a remarkable duration of immunity, suggesting long-term protection benefits.
Assessment includes AI-assisted antigen screening to enhance vaccine effectiveness against RSV.
This early research calls for further development to confirm findings in larger and diverse populations.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Observational analysis reveals durable Th1-biased immunity from an mRNA vaccine against RSV, highlighting its potential in protective strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dong et al. (2026) studied this question.

synapsesocial.com/papers/69a75e23c6e9836116a28851 https://doi.org/10.1016/j.ymthe.2026.01.031

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Targeting the miR-3156-3p/K+ channel axis suppresses viral release and paralysis in enterovirus D68 infectionMolecular Therapy · 2026
2Plugging the diastolic calcium leak: MYBPC3 fragment for CPVT gene therapyMolecular Therapy · 2026
3Dendrimer Delivered shRNA Targeting the CCL20–CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain InjuryMolecular Therapy · 2026
4AAV-mediated CBLN1 replacement rescues hereditary ataxia caused by bi-allelic CBLN1 variantsMolecular Therapy · 2026
5Multiplexed genome editing by CRISPR-Un1Cas12f1 restores dystrophin expression in a mouse model of Duchenne muscular dystrophyMolecular Therapy · 2026
6Combination of bispecific antibodies enable targeted TNFRSF agonism and effective antitumor activityMolecular Therapy · 2026
7BRD4 inhibition mitigates acute and chronic corneal injury following topical nitrogen mustard exposureMolecular Therapy · 2026
8Targeted epigenetic reactivation strategies as new treatments for Prader-Willi syndrome: Achievements and challengesMolecular Therapy · 2026
9Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander diseaseMolecular Therapy · 2026
10Catestatin peptide ameliorates tauopathy and amyloidogenesis via adrenergic inhibitionMolecular Therapy · 2026

More from Molecular Therapy

More from MemorialCare Health System

More from Chinese Pharmaceutical Association